| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.41 | 3e-40 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.39 | 3e-15 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.37 | 6e-14 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-13 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |